India, Aug. 22 -- The landscape of modern medicine in India is undergoing a paradigm shift with cell and gene therapy (CGT) becoming the game-changer in offering potential cures for life-threatening conditions including genetic disorders, cancers, and rare diseases. The advancements in CGTs have registered standout clinical success as compared to conventional treatment methods. The global market is poised for exceptional growth at a compound annual growth rate of 44%, with sales projected to rise from $ 8.70 billion in 2024 to $ 76.03 billion in 2030. With rapidly advancing biotechnology sector and robust government policies, India is also joining the CGT bandwagon of developed countries like the US, China, Japan, Singapore, Malaysia amon...